The company Boiron makes homeopathic flu prevention and relief products. You are probably most familiar with OSCILLOCOCCINUM®, which is used when you already have the flu. 
Did you know that Dolisos/Boiron makes a preventative flu product that is called Influenzinum 9CH and is commonly sold in Canadian pharmacies? Thanks to the internet, those of us here in America can purchase it from the comfort of our home. Note: The Boiron Influenzinum 9C, sold commonly in America, are not the same as the Dolisos/Boiron Influenzinum 9CH.
The formula of Influenzinum 9CH changes each year according to the antegenic variations detected by the World Health Organization surveillance network. The complimentary product that can be taken with Influenzinum 9CH is Thymulin 9CH. Thymulin 9CH is made from oligopeptides that protects and supports the immune system from flu.
Dosage:
Take a 1 single dose tube of INFLUENZINUM 9CH per week for 5 consecutive weeks. This treatment may be administered to people of any age. For young children, dissolve the content of one tube in some water. On a different day, take a 1 single dose tube of THYMULIN 9CH per week for 5 consecutive weeks.
A much smaller amount of INFLUENZINUM 9CH and/or THYMULIN 9CH, such as a few granules, can be taken weekly throughout the winter months for those who want to further enhance protection.
Clinical Evaluation In Influenzal Infection:
A clinical study done on 100 patients followed during 2 winters tested the preventive effect of INFLUENZINUM 9 CH. The treatment was given in the fall with one single dose tube administered per week for 4 weeks, and one dose one month later.
Results: Before the treatment, 82% of the people involved had one episode of influenza each winter, or a similar infection.
1st winter: 78% had neither influenza nor a cold, 11 % had a slight winter rhinitis with no influenza and 11 % had influenza or a cold.
2nd winter: 85% had neither influenza nor a cold, 9 % had a slight winter rhinitis with no influenza and 6% had influenza or cold.
Excerpt from FLU: Alternative Treatments and Prevention
by Randall Neustaedter OMD, North Atlantic Books, 2005
In 1998 the French Society of Homeopathy conducted a survey of 23 homeopathic doctors concerning their use of Influenzinum as a flu preventive (Coulamy, 1998). The survey included use of Influenzinum over a 10 year period (1987-1998) in 453 patients. The protocol for the frequency of doses varied considerably among these doctors. Weekly doses were used by 26 percent of participants and monthly dosage by 23 percent. Another 16 percent used a weekly then monthly dosage plan, and 35 percent applied some other dosage protocol. 80 percent of respondents began treatment in the fall (September through November) and ended between February and April. In this French survey 70 percent of participants used a 9C strength of Influenzinum. (In the US one would assume a higher proportion of practitioners use a higher strength because of the different prescribing preferences between the two countries.)
Results of the survey were remarkable. In approximately 90 percent of the cases no instances of the flu occurred when Influenzinum was used preventively no matter what the dosage protocol. Among the physicians the effectiveness was deemed good to very good in 90 percent of the cases. In 5 percent there was no protective effect. Of the patients, 98 percent expressed a desire to take the same preventive treatment the following year. Certainly this confidence in homeopathic prevention among physicians with many years of experience and their patients speaks to the effectiveness of Influenzinum as a flu preventive. It should be noted that a clinical study that approaches statistical significance evaluating the preventive effects of any homeopathic preparation would probably be prohibitively expensive.
by Randall Neustaedter OMD, North Atlantic Books, 2005
In 1998 the French Society of Homeopathy conducted a survey of 23 homeopathic doctors concerning their use of Influenzinum as a flu preventive (Coulamy, 1998). The survey included use of Influenzinum over a 10 year period (1987-1998) in 453 patients. The protocol for the frequency of doses varied considerably among these doctors. Weekly doses were used by 26 percent of participants and monthly dosage by 23 percent. Another 16 percent used a weekly then monthly dosage plan, and 35 percent applied some other dosage protocol. 80 percent of respondents began treatment in the fall (September through November) and ended between February and April. In this French survey 70 percent of participants used a 9C strength of Influenzinum. (In the US one would assume a higher proportion of practitioners use a higher strength because of the different prescribing preferences between the two countries.)
Results of the survey were remarkable. In approximately 90 percent of the cases no instances of the flu occurred when Influenzinum was used preventively no matter what the dosage protocol. Among the physicians the effectiveness was deemed good to very good in 90 percent of the cases. In 5 percent there was no protective effect. Of the patients, 98 percent expressed a desire to take the same preventive treatment the following year. Certainly this confidence in homeopathic prevention among physicians with many years of experience and their patients speaks to the effectiveness of Influenzinum as a flu preventive. It should be noted that a clinical study that approaches statistical significance evaluating the preventive effects of any homeopathic preparation would probably be prohibitively expensive.
No comments:
Post a Comment